Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
DomainKazal_2

SLCO4C1 SPOCK2 C6

3.02e-0436683PF07648
DomainKAZAL_2

SLCO4C1 SPOCK2 C6

8.00e-0450683PS51465
DomainKazal_dom

SLCO4C1 SPOCK2 C6

8.48e-0451683IPR002350
DomainRhoGAP

MYO9A MYO9B ARHGAP12

1.50e-0362683SM00324
DomainRhoGAP

MYO9A MYO9B ARHGAP12

1.57e-0363683PF00620
DomainZF_DAG_PE_1

MYO9A MYO9B AKAP13

1.64e-0364683PS00479
DomainZF_DAG_PE_2

MYO9A MYO9B AKAP13

1.64e-0364683PS50081
DomainRHOGAP

MYO9A MYO9B ARHGAP12

1.64e-0364683PS50238
DomainRhoGAP_dom

MYO9A MYO9B ARHGAP12

1.64e-0364683IPR000198
Domain-

MYO9A MYO9B ARHGAP12

1.64e-03646831.10.555.10
DomainC1

MYO9A MYO9B AKAP13

1.72e-0365683SM00109
DomainPE/DAG-bd

MYO9A MYO9B AKAP13

1.79e-0366683IPR002219
DomainKRAB

ZNF776 ZNF274 ZNF256 ZNF429 ZNF79 ZNF248

1.92e-03358686PS50805
DomainKRAB

ZNF776 ZNF274 ZNF256 ZNF429 ZNF79 ZNF248

1.92e-03358686PF01352
DomainKRAB

ZNF776 ZNF274 ZNF256 ZNF429 ZNF79 ZNF248

2.23e-03369686SM00349
DomainKRAB

ZNF776 ZNF274 ZNF256 ZNF429 ZNF79 ZNF248

2.26e-03370686IPR001909
DomainFibrinogen_a/b/g_C_2

FCN1 ANGPTL7

3.42e-0324682IPR014715
Domain-

FCN1 ANGPTL7

3.42e-03246824.10.530.10
DomainRho_GTPase_activation_prot

MYO9A MYO9B ARHGAP12

4.06e-0388683IPR008936
DomainFibrinogen_C

FCN1 ANGPTL7

4.32e-0327682PF00147
DomainFBG

FCN1 ANGPTL7

4.98e-0329682SM00186
Domain-

FCN1 ANGPTL7

5.32e-03306823.90.215.10
DomainFibrinogen_a/b/g_C_1

FCN1 ANGPTL7

5.32e-0330682IPR014716
DomainRA

MYO9A MYO9B

5.67e-0331682SM00314
DomainFIBRINOGEN_C_1

FCN1 ANGPTL7

6.04e-0332682PS00514
DomainFibrinogen_a/b/g_C_dom

FCN1 ANGPTL7

6.04e-0332682IPR002181
DomainFIBRINOGEN_C_2

FCN1 ANGPTL7

6.04e-0332682PS51406
DomainRA

MYO9A MYO9B

7.60e-0336682PF00788
DomainRA

MYO9A MYO9B

8.01e-0337682PS50200
DomainMyosin_head_motor_dom

MYO9A MYO9B

8.44e-0338682IPR001609
DomainMYOSIN_MOTOR

MYO9A MYO9B

8.44e-0338682PS51456
DomainMyosin_head

MYO9A MYO9B

8.44e-0338682PF00063
DomainMYSc

MYO9A MYO9B

8.44e-0338682SM00242
Pubmed

The in vivo Interaction Landscape of Histones H3.1 and H3.3.

FSIP2 ZNF776 TCF20 PSIP1 BCL7C SGO2 PUM3 CHD6 MSH3 QSER1 ATAD2

4.22e-08608711136089195
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

SPTLC3 BMPR2 PPP2R3A FYTTD1 MYO9A GLI2 AFF1 AKAP13 CHD6 QSER1 VPS13B PCM1 ZNF248 TASOR2

1.60e-061489711428611215
Pubmed

Class IX Myosins: Motorized RhoGAP Signaling Molecules.

MYO9A MYO9B

4.11e-06271232451867
Pubmed

Acute necrotizing encephalopathy-linked mutations in Nup358 impair interaction of Nup358 with TNRC6/GW182 and miRNA function.

RANBP2 TNRC6A

4.11e-06271233962210
Pubmed

An improved smaller biotin ligase for BioID proximity labeling.

FSIP2 NCOR1 RANBP2 CCDC88A TCF20

5.51e-0612371526912792
Pubmed

Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.

NCOR1 RANBP2 SPATS2L FMN1 ARHGAP12 OTUD4 CHD6 PCM1

5.72e-0647571831040226
Pubmed

Identification of heat shock factor 1 molecular and cellular targets during embryonic and adult female meiosis.

SGO2 MSH3 TEX15

1.22e-052271321690297
Pubmed

The association of four SNPs in DNA mismatch repair genes with idiopathic male infertility in northwest China.

MLH3 MSH3

1.23e-05371231342644
Pubmed

HIV DNA integration.

RANBP2 PSIP1

1.23e-05371222762018
Pubmed

MutLalpha and proliferating cell nuclear antigen share binding sites on MutSbeta.

MLH3 MSH3

1.23e-05371220154325
Pubmed

An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.

MAGEB2 CCDC88A TCF20 TNRC6A AKAP13 CHD6 QSER1 ADCY9 PCM1

1.81e-0573371934672954
Pubmed

The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.

NCOR1 RANBP2 GTF2E2 TCF20 PSIP1 SGO2 PUM3 QSER1 PCM1 TASOR2

2.34e-05954711036373674
Pubmed

Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.

NCOR1 RANBP2 CCDC88A TCF20 TNRC6A CHD6 PCM1

2.36e-0541871734709266
Pubmed

BIG1 is a binding partner of myosin IXb and regulates its Rho-GTPase activating protein activity.

MYO9A MYO9B

2.46e-05471215644318
Pubmed

TEX15 is an essential executor of MIWI2-directed transposon DNA methylation and silencing.

TEX15 TASOR2

2.46e-05471232719317
Pubmed

Molecular mechanisms of retroviral integration site selection.

RANBP2 PSIP1

2.46e-05471225147212
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

NCOR1 RANBP2 TCF20 PSIP1 BCL7C OTUD4 AFF1 ATAD2 PCM1

2.78e-0577471915302935
Pubmed

Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.

NCOR1 ZNF776 TTLL5 TNRC6A PCM1

3.85e-0518471532908313
Pubmed

The human cytoplasmic dynein interactome reveals novel activators of motility.

NCOR1 RANBP2 PPP2R3A CCDC88A TTLL5 PKP4 ARHGAP12 TNRC6A PCM1

5.89e-0585371928718761
Pubmed

A human MAP kinase interactome.

RANBP2 CCDC88A TCF20 MYO9A TNRC6A AKAP13 CHD6

6.13e-0548671720936779
Pubmed

Degree of predicted minor histocompatibility antigen mismatch correlates with poorer clinical outcomes in nonmyeloablative allogeneic hematopoietic cell transplantation.

PUM3 AKAP13

6.13e-05671220353833
Pubmed

Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy.

ZNF776 FYTTD1 TRPC6 CKAP2L MSH3 CEP126 ATAD2 VPS13B

7.84e-0568671829987050
Pubmed

Interaction network of human early embryonic transcription factors.

NCOR1 RANBP2 TCF20 BCL7C MSH3 QSER1

8.35e-0535171638297188
Pubmed

Common germline variation in mismatch repair genes and survival after a diagnosis of colorectal cancer.

MLH3 MSH3

8.57e-05771219115210
Pubmed

Tails of unconventional myosins.

MYO9A MYO9B

8.57e-05771211212352
Pubmed

Mismatch repair gene polymorphisms and survival in invasive ovarian cancer patients.

MLH3 MSH3

8.57e-05771218723338
Pubmed

Common variants in mismatch repair genes and risk of invasive ovarian cancer.

MLH3 MSH3

8.57e-05771216774946
Pubmed

Common variants in mismatch repair genes and risk of colorectal cancer.

MLH3 MSH3

8.57e-05771218364438
Pubmed

New insights in the role of nucleoporins: a bridge leading to concerted steps from HIV-1 nuclear entry until integration.

RANBP2 PSIP1

8.57e-05771224051001
Pubmed

Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.

RANBP2 MLH3 TCF20 MSH3 REV3L

9.36e-0522271537071664
Pubmed

FAN1 controls mismatch repair complex assembly via MLH1 retention to stabilize CAG repeat expansion in Huntington's disease.

MLH3 MSH3

1.14e-04871234469738
Pubmed

Localization of MMR proteins on meiotic chromosomes in mice indicates distinct functions during prophase I.

MLH3 MSH3

1.14e-04871216260499
Pubmed

Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma.

BMPR2 CCDC88A FMN1 PKP4 ITGAV ADCY9

1.23e-0437771638117590
Pubmed

Nuclear monomeric integrin αv in cancer cells is a coactivator regulated by thyroid hormone.

NCOR1 ITGAV

1.47e-04971223640055
Pubmed

Role of minor histocompatibility antigens in renal transplantation.

PUM3 AKAP13

1.47e-04971218093280
Pubmed

Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry.

RANBP2 ARHGAP12 OTUD4 PCM1

1.63e-0413371415144186
Pubmed

Polymorphism discovery in 62 DNA repair genes and haplotype associations with risks for lung and head and neck cancers.

MLH3 MSH3

1.83e-041071217494052
Pubmed

Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.

NCOR1 GTF2E2 PPP2R3A CCDC88A TNRC6A ADCY9 PCM1 TASOR2

1.84e-0477771835844135
Pubmed

Transcription factor protein interactomes reveal genetic determinants in heart disease.

NCOR1 RANBP2 FYTTD1 PSIP1 KDM5D TASOR2

1.97e-0441171635182466
Pubmed

RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.

RANBP2 CCDC88A TCF20 TNRC6A VPS13B

2.06e-0426371534702444
Pubmed

A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal.

NCOR1 RANBP2 SGO2 QSER1

2.33e-0414671423892456
Pubmed

Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.

NCOR1 GLI2 AFF1 AKAP13 KDM5D TASOR2

2.51e-0443071635044719
Pubmed

The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.

FYTTD1 SPATS2L TNRC6A CKAP2L

2.71e-0415271438360978
Pubmed

Multiple loci influencing hippocampal degeneration identified by genome scan.

CHD6 VPS13B

3.16e-041371222745009
Pubmed

Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.

MAP9 FYTTD1 FMN1 ZNF429 OTUD4 AFF1 SPOCK2 QSER1 VPS13B

3.53e-04108471911544199
Pubmed

Identification and overlapping expression of multiple unconventional myosin genes in vertebrate cell types.

MYO9A MYO9B

3.68e-04147128022818
Pubmed

Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.

RANBP2 PSIP1 BCL7C TNRC6A CHD6 TASOR2

3.98e-0446971627634302
Pubmed

HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.

GTF2E2 FYTTD1 SPATS2L PSIP1 TNRC6A OTUD4 CKAP2L PUM3 ITGAV PCM1

4.54e-041371711036244648
Pubmed

Systematic interactome mapping of acute lymphoblastic leukemia cancer gene products reveals EXT-1 tumor suppressor as a Notch1 and FBWX7 common interactor.

MLH3 TNRC6A CEP126 TASOR2

4.73e-0417671427229929
Pubmed

An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase.

NCOR1 TCF20 PKP4 TNRC6A

5.14e-0418071435198878
Pubmed

Probing nuclear pore complex architecture with proximity-dependent biotinylation.

RANBP2 CD1E FMN1

5.35e-047771324927568
Pubmed

Agonist-specific Protein Interactomes of Glucocorticoid and Androgen Receptor as Revealed by Proximity Mapping.

NCOR1 SPATS2L TCF20

5.56e-047871328611094
Pubmed

Proteomic analysis reveals novel ligands and substrates for LNX1 E3 ubiquitin ligase.

GTF2E2 AKAP13 PCM1

5.77e-047971329121065
Pubmed

Human transcription factor protein interaction networks.

NCOR1 TCF20 GLI2 BCL7C TNRC6A OTUD4 PUM3 CHD6 QSER1 PCM1

6.27e-041429711035140242
Pubmed

Candidate malaria susceptibility/protective SNPs in hospital and population-based studies: the effect of sub-structuring.

C6 ADCY9

6.87e-041971220459687
Pubmed

Genetic polymorphisms in 85 DNA repair genes and bladder cancer risk.

MLH3 MSH3 REV3L

6.90e-048471319237606
Pubmed

Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma.

SPATS2L PSIP1 MYO9A MYO9B PKP4 TNRC6A CKAP2L

7.36e-0473271734732716
Pubmed

The ubiquitin ligase Uhrf2 is a master regulator of cholesterol biosynthesis and is essential for liver regeneration.

RANBP2 SGO2 TASOR2

7.39e-048671337253089
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

NCOR1 RANBP2 CCDC88A TCF20 PKP4 OTUD4 QSER1 PCM1

7.65e-0496371828671696
Pubmed

Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.

GTF2E2 CCDC88A COCH PSIP1 TTLL5 PKP4 AKAP13 VPS13B ADCY9 PCM1

8.50e-041487711033957083
Pubmed

Transcriptome analysis of mouse stem cells and early embryos.

MAGEB2 SPATS2L ZNF274 SGO2 CHD6

8.92e-0436371514691545
Pubmed

The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.

RANBP2 GTF2E2 FYTTD1 SPATS2L PKP4 TNRC6A OTUD4 PUM3 CHD6 ATAD2

8.95e-041497711031527615
Pubmed

Interactomes of Glycogen Synthase Kinase-3 Isoforms.

CCDC88A MYO9A TNRC6A PCM1

8.99e-0420971436779422
Pubmed

The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.

MAGEB2 FYTTD1 PSIP1 MYO9B CKAP2L SGO2 PUM3

9.09e-0475971735915203
Pubmed

Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach.

RANBP2 MYO9A MYO9B MSH3

9.31e-0421171417314511
Pubmed

Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.

NCOR1 CCDC88A MYO9A MYO9B TNRC6A PCM1

1.29e-0358871638580884
Pubmed

Docking of HIV-1 Vpr to the nuclear envelope is mediated by the interaction with the nucleoporin hCG1.

RANBP2 PSIP1

1.29e-032671212228227
Pubmed

Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.

NCOR1 RANBP2 PPP2R3A CCDC88A PKP4 TNRC6A OTUD4 ADCY9

1.32e-03104971827880917
Pubmed

USP45 and Spindly are part of the same complex implicated in cell migration.

OTUD4 SGO2 MSH3 PCM1

1.38e-0323571430258100
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

TCF20 OTUD4 SPOCK2 CHD6 VPS13B

1.48e-0340771512693553
Pubmed

Identification, replication, and fine-mapping of Loci associated with adult height in individuals of african ancestry.

CCDC88A TTLL5

1.61e-032971221998595
Pubmed

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

RANBP2 TCF20 MYO9A MYO9B PKP4 PUM3 AKAP13 MSH3 ATAD2

1.69e-03135371929467282
Pubmed

A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.

CCDC88A FYTTD1 PKP4 ITGAV ADCY9

1.72e-0342171536976175
Pubmed

Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.

NCOR1 RANBP2 PSIP1 MYO9B MSH3 QSER1 REV3L

1.82e-0385771725609649
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

FSIP2 BMPR2 CCDC88A TCF20 MYO9A AKAP13 PCM1

1.87e-0386171736931259
InteractionRHOF interactions

BMPR2 CCDC88A MYO9B PKP4 ARHGAP12 MSH3 QSER1 ATAD2 ITGAV VPS13B ADCY9

1.44e-056736811int:RHOF
InteractionRHOV interactions

BMPR2 CCDC88A MYO9A PKP4 ARHGAP12 ITGAV ADCY9

1.76e-05243687int:RHOV
Cytoband19q13.43

ZNF776 ZNF256 C19orf18 NLRP13

1.06e-058771419q13.43
Cytoband11q22.1

TRPC6 CEP126

2.12e-041471211q22.1
Cytoband8p12

GTF2E2 TEX15

2.44e-03477128p12
Cytoband19p13.1

MYO9B ZNF429

2.54e-034871219p13.1
Cytoband2q33.1

SPATS2L SGO2

2.86e-03517122q33.1
Cytoband9q34

FCN1 ZNF79

3.20e-03547129q34
Cytoband11p13

CCDC73 QSER1

3.44e-035671211p13
CytobandEnsembl 112 genes in cytogenetic band chr2q33

BMPR2 SPATS2L SGO2

4.01e-03205713chr2q33
CytobandEnsembl 112 genes in cytogenetic band chr11p13

CCDC73 QSER1

4.61e-0365712chr11p13
CytobandEnsembl 112 genes in cytogenetic band chr18q22

SOCS6 CDH7

4.89e-0367712chr18q22
CytobandEnsembl 112 genes in cytogenetic band chr8p12

GTF2E2 TEX15

5.62e-0372712chr8p12
Cytoband14q24.3

MLH3 TTLL5

9.21e-039371214q24.3
CytobandEnsembl 112 genes in cytogenetic band chr19q13

ZNF776 ZNF274 ZNF256 C19orf18 LILRA5 NLRP13

1.03e-021192716chr19q13
GeneFamilyMyosins, class IX

MYO9A MYO9B

6.61e-0624721103
GeneFamilyEndogenous ligands|Minor histocompatibility antigens

PUM3 AKAP13 KDM5D

3.14e-0451473870
GeneFamilyFibrinogen C domain containing

FCN1 ANGPTL7

1.91e-0325472554
GeneFamilyZinc fingers C2H2-type|ZF class homeoboxes and pseudogenes

ZNF776 ZNF274 GLI2 ZNF256 ZNF429 ZNF79 ZNF248

2.38e-0371847728
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_DN

RANBP2 GTF2E2 PPP2R3A MYO9B PKP4 ARHGAP12 OTUD4 AFF1 PUM3 AKAP13 MSH3 SOCS6 REV3L VPS13B ADCY9

6.14e-098567015M4500
CoexpressionHAMAI_APOPTOSIS_VIA_TRAIL_UP

PPP2R3A CCDC88A MYO9A PUM3 MSH3 QSER1 REV3L ATAD2 ITGAV PCM1 TASOR2

1.26e-066567011M18979
CoexpressionGRYDER_PAX3FOXO1_ENHANCERS_IN_TADS

SPATS2L TCF20 PSIP1 MYO9A MYO9B ARHGAP12 CHD6 MSH3 PDGFC VPS13B ADCY9 PCM1

1.35e-0510097012M157
CoexpressionDAZARD_UV_RESPONSE_CLUSTER_G6

MLH3 OTUD4 REV3L VPS13B ADCY9

4.38e-05145705M1810
ToppCelldroplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MAP9 BMPR2 CCDC88A MYO9A C6 PDGFC

3.62e-0717770614fb8d182775dfd0e49aa7e4e12543a85b3b8bd6
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SPTLC3 PPP2R3A MYO9A PKP4 PUM3 RP1

5.00e-07187706c31130fc2f9f882944b2ba366a034a03f051c4b9
ToppCellTCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9

MAP9 RANBP2 AFF1 MSH3 VPS13B TASOR2

6.02e-07193706abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_T-T4_reg-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

SPATS2L PSIP1 SPOCK2 KDM5D PCM1

7.63e-061727059497948bbe53fb88c6ff6b347f743d456da587e5
ToppCelldroplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RANBP2 BMPR2 CCDC88A MYO9A PCM1

8.52e-06176705749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCelldroplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MAP9 BMPR2 MYO9A C6 PDGFC

8.52e-061767055e46a09a36b9645b1b1fcb0b64bd0898561af3a9
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PPP2R3A SLCO4C1 FMN1 PKP4 RP1

1.09e-0518570503f64a7132b13a01ba47187e0e15c13ac88f7cb2
ToppCellsaliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

MAP9 PSIP1 ZNF256 SPOCK2 CHD6

1.11e-05186705bbcd9062c0f6f65ca6f3cb101b6fa72ddd1e14fe
ToppCellSmart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CKAP2L SGO2 ATAD2 C19orf18 NLRP13

1.11e-0518670586d145f965c311189e7996390eef491642417c5c
ToppCellAnterior_Cingulate_gyrus_(CgG)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

COCH ARHGAP12 TRPC6 PUM3 PDGFC

1.11e-0518670532af3f211f9ad5d5c6b86b83325cfbf2f8466b56
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SPTLC3 PPP2R3A MYO9A PKP4 RP1

1.11e-05186705f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SPTLC3 PPP2R3A MYO9A PKP4 RP1

1.17e-05188705af740fa78542438fdff627ea1f74f4eee43316be
ToppCell10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_dendritic-CD1c-positive_myeloid_dendritic_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

CD1E CCDC88A FCN1 PDGFC LILRA5

1.20e-05189705e4b2f00cb3675a4d94e8807d6ff99cc55f9ed233
ToppCellnucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

MYO9B FMN1 AFF1 AKAP13 VPS13B

1.33e-05193705779276e775cb2492e8dd36436295a536084a6415
ToppCell3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MAP9 RP1 C6 CEP126 LRRC36

1.33e-05193705bdb7401dd9059032f930f2b575f2ef8e504b6594
ToppCellSmart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

PSIP1 CKAP2L SGO2 REV3L ATAD2

1.36e-051947057a66bd7d4fc9c6db861cedd2487f241e406869d1
ToppCellmoderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

MAP9 PSIP1 SGO2 CEP126 PCM1

1.36e-051947055dffa578149104dda33774361e9e77b227b5f1ce
ToppCell3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SPTLC3 SLCO4C1 AKAP13 MUCL3 LRRC36

1.43e-051967057e5addaa844e66f8160e05858c341866a80aed23
ToppCellmLN-Dendritic_cell-cDC2|mLN / Region, Cell class and subclass

CD1E PPP2R3A CCDC88A SPATS2L LILRA5

1.54e-05199705cb17bccb47d04f7793709f9a4376fcc8ce95430c
ToppCellCaecum-(5)_Dendritic_cell-(50)_cDC2|Caecum / shred on region, Cell_type, and subtype

CD1E SLCO4C1 TRPC6 PDGFC LILRA5

1.54e-05199705bf8a10a9db7e8e0a6e2b53747949f442fe0e581e
ToppCellmLN-(5)_Dendritic_cell-(50)_cDC2|mLN / shred on region, Cell_type, and subtype

CD1E PPP2R3A CCDC88A SPATS2L LILRA5

1.54e-051997058d1b18596a0965427abefe0be744c74e4c11d5d3
ToppCellCaecum-Dendritic_cell-cDC2|Caecum / Region, Cell class and subclass

CD1E SLCO4C1 TRPC6 PDGFC LILRA5

1.54e-05199705944c567307082dd54dc141e93965d46f4ec8bc1f
ToppCell(5)_Epithelial_cells-(5)_Epi_dividing|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)

PSIP1 BCL7C CKAP2L SGO2 ATAD2

1.58e-05200705b46b2064362efc64edf19ab2b21bc89047c9d943
ToppCellcritical-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

PSIP1 BCL7C SGO2 REV3L ATAD2

1.58e-05200705f39db4250ce220a3eb58edee3f7fc3671701d46f
ToppCell356C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

CD1E PSIP1 CKAP2L SGO2 ATAD2

1.58e-052007055b014c658eecc5e73679e5feb7a2aaa3d297001d
ToppCell(50)_cDC2|World / shred on Cell_type and subtype

CD1E CCDC88A SPATS2L TRPC6 LILRA5

1.82e-05206705d519adeb8290fcce107e81a439ba3bf1e231b55b
ToppCellsaliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)

ZNF256 SPOCK2 TMC3 ZNF248

8.94e-051497044b44108c40376a6b73258df40d2424e68f991383
ToppCellfacs-Marrow-T_cells-18m-Lymphocytic-lymphoid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PPP2R3A TRPC6 LRRC36 ADCY9

9.65e-05152704acfafdb64bd5b0eb7371b04cfef51ed2798e9b30
ToppCellfacs-Marrow-T_cells-18m-Lymphocytic-common_lymphoid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PPP2R3A TRPC6 LRRC36 ADCY9

9.65e-051527049d6c88ceca0569dbeb12e488acec7fcb7f972f03
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

FCN1 CKAP2L ZNF723 ANGPTL7

9.90e-0515370483942ef63d21725fa15ed5a91481d1f9936e8f11
ToppCellBAL-Severe-Myeloid-cDC-cDC-cDC_6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

SPTLC3 CD1E TRPC6 REV3L

1.07e-041567040f2147abcf31a26ee5b2f4d8c5d72232612a33f0
ToppCellBAL-Severe-Myeloid-cDC-cDC-cDC_6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SPTLC3 CD1E TRPC6 REV3L

1.07e-04156704cb87f12443fdc5538b856f765fcbac9406044e10
ToppCellPBMC-Severe-Myeloid-cDC-cDC-cDC_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CD1E MAGEB2 CCDC88A SPATS2L

1.09e-04157704e9d0300361b06aec3c216f8af15f09e14b12a4da
ToppCellsaliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

ZNF256 SPOCK2 TMC3 ZNF248

1.09e-041577040a552abfd139afc8516c38ca568f9922511dddce
ToppCellPBMC-Severe-Myeloid-cDC-cDC-cDC_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

CD1E MAGEB2 CCDC88A SPATS2L

1.12e-04158704e9657d8960d499832f9f9b45b5a6f4388551b7e1
ToppCellsaliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

MAP9 SPOCK2 ZNF79 KDM5D

1.15e-041597042233fee5dcdb6c7dee5b1bd8efbc07d86b339927
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SPTLC3 PPP2R3A MYO9A RP1

1.29e-041647041cb5fbd7050650047ad6f2ca792118e98d58d22b
ToppCellmild-Myeloid-CD14_Monocytes_3|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

CCDC88A SPATS2L FCN1 LILRA5

1.32e-04165704a6547bb2c9c40b4878325da19b9def0ef644fa25
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_naive-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SLCO4C1 CCDC73 FCN1 LILRA5

1.39e-041677041cd9e2af85c6c5b9e1d88991c87ac6980b387243
ToppCell10x5'-Lung-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|Lung / Manually curated celltypes from each tissue

FCN1 CKAP2L SGO2 LILRA5

1.39e-0416770482739226347d74897be000f429b73543a031af96
ToppCell10x5'-Lung-Hematopoietic_progenitors|Lung / Manually curated celltypes from each tissue

FCN1 CKAP2L SGO2 LILRA5

1.39e-04167704dec18caf0475002d4ad3c7bc7fc3050cbc8e6bae
ToppCellDividing_Macrophages-IPF_04|World / lung cells shred on cell class, cell subclass, sample id

CCDC88A CKAP2L SGO2 ATAD2

1.45e-04169704bc859a103cad567caf50c3c3882d2d2017807c73
ToppCellBrain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating-cycling_ventral_progenitors|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.

SLCO4C1 CKAP2L SGO2 ATAD2

1.49e-0417070473601c873b177d5d134618d8e228c51381119f7d
ToppCellPND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CCDC88A CKAP2L SGO2 LILRA5

1.52e-04171704845f312f8cbe29d820da25f0e6d75deb382bbfd8
ToppCell10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic-non-classical_monocyte|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

CCDC88A FMN1 PDGFC LILRA5

1.55e-04172704968d18ab8c3cdeb7936a2aa721a7f41525763863
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

FMN1 CKAP2L ATAD2 LILRA5

1.55e-04172704ef33b5e0515c6d29fb6d9a673011c1b68ef264f3
ToppCell10x5'-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|lymph-node_spleen / Manually curated celltypes from each tissue

CCDC88A FCN1 CKAP2L LILRA5

1.59e-04173704783b8fa08b9d8f597f251793eae164151662f1f9
ToppCellPND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CCDC88A CKAP2L SGO2 ATAD2

1.62e-0417470465147b0f8c2ccadd5685430d31081520c157536a
ToppCell3'-Distal_airway-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PSIP1 CKAP2L SGO2 PCM1

1.62e-041747040227fea1678baa9168bd47c3b4aacb2592bb5867
ToppCell3'-Distal_airway-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PSIP1 CKAP2L SGO2 PCM1

1.62e-04174704c2f8c59fca5f1ff6ffa6dc8cfce62da4b19fe9b3
ToppCell3'-Distal_airway-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PSIP1 CKAP2L SGO2 PCM1

1.62e-0417470484024c04b0ce9f7068677d2d99ede56882b7dbd2
ToppCellRSV-Healthy-1|Healthy / Virus stimulation, Condition and Cluster

SPATS2L SLCO4C1 MYO9B SOCS6

1.66e-04175704ff3a27f512a3a710ebc863b7b75cce8167d5440b
ToppCellRSV-Healthy-1|RSV / Virus stimulation, Condition and Cluster

SPATS2L SLCO4C1 MYO9B SOCS6

1.66e-04175704ca52b99b03535a5b3a2751d6981708dc5b255b91
ToppCellsystemic_lupus_erythematosus-flare-Myeloid-conventional_dendritic_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CD1E CCDC88A TRPC6 KDM5D

1.66e-04175704c58a1f02d1e559d3638fe1500e960e82a8a7187b
ToppCellCiliated_cells-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id

RP1 C6 CEP126 TMC3

1.73e-04177704c38138fb5ad9766c2d240811210c854338cd612e
ToppCell367C-Myeloid-Dendritic-cDC_proliferating_1|367C / Donor, Lineage, Cell class and subclass (all cells)

CD1E CKAP2L SGO2 ATAD2

1.73e-04177704ba701d3c90722d8bff70d0fa651899305cdad257
ToppCell390C-Lymphocytic-CD4_T-cell-Treg_cell_2|390C / Donor, Lineage, Cell class and subclass (all cells)

COCH TTLL5 SGO2 SPOCK2

1.77e-04178704829ea00c022a78d1861aa3ec53503272976775d9
ToppCellPND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SLCO4C1 C6 TEX15 ATAD2

1.81e-04179704bf012825e88626e59cd1deebf67c2cd269ce4829
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PPP2R3A FMN1 PKP4 RP1

1.85e-041807049e09b3dfe344b5d50520711513d389865d73a861
ToppCell5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

COCH CKAP2L SGO2 ATAD2

1.89e-0418170473b1b59810f60e3e39ca1d5073a5a0d4f5377e6e
ToppCellHealthy_Control-Lymphoid-T-|Healthy_Control / Condition, Lineage, Cell class and cell subclass

CCDC73 CKAP2L SGO2 ATAD2

1.89e-04181704ac1ee313910c05b1b3cb497bae14565464919c21
ToppCellASK454-Epithelial|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq

SPOCK2 RP1 C6 ANGPTL7

1.93e-04182704ab15316cff989b61ff397a866d7ca8b49c13e981
ToppCelldroplet-Marrow-nan-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CCDC88A SOCS6 ATAD2 PCM1

1.93e-04182704bc8d621be57f76d718d9b0f11e023b0f4dcb668d
ToppCellcellseq2-Immune-Immune_Myeloid-Myeloid_Dendritic-cDC2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

CD1E CCDC88A FCN1 LILRA5

1.97e-041837049840706f972387241bf1d4ba8af25efc3214a91b
ToppCellcellseq2-Immune-Immune_Myeloid-Myeloid_Dendritic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

CD1E CCDC88A FCN1 LILRA5

1.97e-04183704409cb52cf4c967e52bf75a6680bcbe87f638c75d
ToppCelldroplet-Lung-18m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

COCH CKAP2L SGO2 SPOCK2

2.01e-041847041edefa2a049d7e22d0bdb1ea3d7ef1c8d6ae0fe3
ToppCellCOVID-19_Convalescent-Myeloid-cDC|COVID-19_Convalescent / Disease group, lineage and cell class

CD1E CCDC88A SPATS2L TRPC6

2.01e-04184704ad6e910eaebe841a68a5f2f329d43dafc5db158a
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SPTLC3 FMN1 PKP4 RP1

2.01e-04184704d33de57876817050b294f2ecb0a4eb0634cfa7f0
ToppCellPBMC-Convalescent-Myeloid-cDC-cDC|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

CD1E CCDC88A SPATS2L TRPC6

2.01e-041847049d678b24532b7763f2e73f7ccb496259977c5204
ToppCellPBMC-Convalescent-Myeloid-cDC-cDC-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

CD1E CCDC88A SPATS2L TRPC6

2.01e-04184704383374ad17bd322b8d703a22e475d34ca7b2e6b6
ToppCelldroplet-Lung-18m-Hematologic-lymphocytic-Proliferating_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

COCH CKAP2L SGO2 SPOCK2

2.01e-041847048578c50eaa8ce1cefc0228185c66c8e25f4bfc32
ToppCellPBMC-Convalescent-Myeloid-cDC|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09)

CD1E CCDC88A SPATS2L TRPC6

2.01e-041847045535b85b3ad3d0c0392d5884fdc2939c7e1b1c3e
ToppCellsaliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

MAP9 ZNF256 SPOCK2 KDM5D

2.05e-04185704f1263899a2d41d182022dc4ca62cbae08a463c89
ToppCellCOVID_vent-Myeloid-Dendritic|COVID_vent / Disease condition, Lineage, Cell class and subclass

CD1E MAGEB2 CCDC88A SPATS2L

2.10e-0418670463a5cdd3f60681762a218be32db84be8f29b88fd
ToppCell3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-cDC2|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CD1E CCDC88A FCN1 LILRA5

2.10e-0418670444785bd171f424ad61437275026439fae3cb8d8c
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PPP2R3A FMN1 PKP4 RP1

2.10e-041867041850583d23903d08226aeb0edb3e07b0994330e4
ToppCell10x5'-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|bone_marrow / Manually curated celltypes from each tissue

CCDC88A FCN1 CKAP2L SGO2

2.10e-04186704e82d5e7a976b9cfa2b4640c7a7cd1cfea19c4806
ToppCellCOVID_vent-Myeloid-Dendritic-cDC|COVID_vent / Disease condition, Lineage, Cell class and subclass

CD1E MAGEB2 CCDC88A SPATS2L

2.10e-0418670439457a7b43537f2c3e221f9375c95d4515424d7d
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PPP2R3A FMN1 PKP4 RP1

2.10e-041867044dafc215c42e7949f932a3627359c107943b5d6b
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

GLI2 CKAP2L SGO2 ATAD2

2.14e-04187704e41e39fd3791acf8ae5376cc5061e196d96868ae
ToppCell3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|lymph-node_spleen / Manually curated celltypes from each tissue

SLCO4C1 SGO2 QSER1 LILRA5

2.14e-041877043c10b8501226c69d71bcd99dc1c064a3c2154f87
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

GLI2 CKAP2L SGO2 ATAD2

2.14e-04187704cefa211ef224e803ea9467882e2ca74d0b1492f1
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

SLCO4C1 FMN1 AKAP13 LRRC36

2.14e-041877045df9e1f5ca32217af255e76e6fb5afa346337811
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

CCDC88A CKAP2L SGO2 ATAD2

2.14e-0418770473931a5ea73799095daff100b5f18853c57c74dc
ToppCellwk_08-11-Hematologic-Myeloid-Promonocyte-like|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

CD1E SLCO4C1 FCN1 LILRA5

2.18e-041887042ae945d96a011f246d04a42bcd6ef443232b03f4
ToppCellFibroblast-E_(Early_Fibroblastic_progenitor)|World / shred on cell class and cell subclass (v4)

PSIP1 CKAP2L SGO2 ATAD2

2.18e-04188704be3db9768364568f44e32ae6b3bf99e49b0978bb
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_T-T4_reg|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

SPATS2L PSIP1 SPOCK2 MUCL3

2.18e-04188704e5c480b9a030536578f1cc91fb61738f752525b3
ToppCellPND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SPTLC3 MAP9 RP1 LRRC36

2.23e-04189704b55de812043b670cbde810d7d42f45909b6d66ef
ToppCellPND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SPTLC3 MAP9 RP1 LRRC36

2.23e-041897044e83e49d1265ffe507fdb72924c77c4d1c73f0bd
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

SPTLC3 PPP2R3A MYO9A RP1

2.27e-04190704bf4511395fa97efd1c1cd17cc9bebb0271ee7f0e
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

SPTLC3 PPP2R3A MYO9A RP1

2.27e-04190704b6b8964b4910083499681b5fdf554e127b6a4c4e
ToppCellControl-Myeloid-Transitioning_MDM|Control / group, cell type (main and fine annotations)

CCDC88A MYO9B FCN1 FMN1

2.27e-04190704d6fd8c23cde4a10cc1517b6899a5a855fdfff2e2
ToppCellPND10-Epithelial-Epithelial_Alveolar|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SLCO4C1 SPOCK2 C6 TEX15

2.27e-04190704dc20d323cee2741e39fba597263d6418ae0eadaf
ToppCellPND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SLCO4C1 SPOCK2 C6 TEX15

2.27e-04190704ec1bd4929dc82bec2c983a31ece4e3aa82f3a2ab
ToppCell(01)_Dendritic_cell|World / immune cells in Peripheral Blood (logTPM normalization)

CD1E CCDC88A SPATS2L LRRC36

2.32e-041917041f4c8078e1a6cd14937c714330af608caced2acf
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CKAP2L SGO2 SPOCK2 ATAD2

2.32e-04191704912e2d10d3423aa7f708fcf2b11da1845f12d7d3
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_T-T4_reg-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

SPATS2L PSIP1 SPOCK2 MUCL3

2.32e-04191704c5e22df4a8741b8096cdd1618271fd48d6265846
ToppCell3'_v3-bone_marrow-Myeloid_Dendritic-Cycling_Dendritic|bone_marrow / Manually curated celltypes from each tissue

CD1E CCDC88A SPATS2L SGO2

2.32e-04191704aa9c0b1b90cdb7a95d4e6332819f82cae0a79ff9
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

SPTLC3 PPP2R3A MYO9A RP1

2.32e-041917042fa1b9e76a0ed2d2f0de74349e266cf4a5f51aad
ToppCellCOVID-19-kidney-TAL|COVID-19 / Disease (COVID-19 only), tissue and cell type

SPTLC3 PPP2R3A PKP4 RP1

2.32e-04191704fe55475ce0666ab5122447a813dc2369e24947b8
ComputationalGenes upregulated in subsets of cells of a given type within various tumors

RANBP2 ATAD2 PCM1 TASOR2

6.93e-0550484GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN
DrugPiperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; PC3; HT_HG-U133A

SPTLC3 CCDC88A AKAP13 SPOCK2 CDH7 PCM1

2.72e-051946964320_DN
DrugClioquinol [130-26-7]; Down 200; 13uM; HL60; HT_HG-U133A

BMPR2 MLH3 ZNF79 QSER1 SOCS6 ADCY9

2.80e-051956963084_DN
DrugRiboflavine [83-88-5]; Up 200; 10.6uM; MCF7; HT_HG-U133A

MAGEB2 FCN1 TTLL5 AFF1 SPOCK2 VPS13B

2.80e-051956966822_UP
DrugProparacaine hydrochloride [5875-06-9]; Down 200; 12uM; HL60; HT_HG-U133A

BMPR2 MYO9A PKP4 OTUD4 ZNF79 ADCY9

2.88e-051966963113_DN
DrugCefepime hydrochloride [123171-59-5]; Down 200; 7.4uM; MCF7; HT_HG-U133A

PPP2R3A MLH3 COCH MYO9A TTLL5 PCM1

2.96e-051976966237_DN
DrugSulfamonomethoxine [1220-83-3]; Up 200; 14.2uM; PC3; HT_HG-U133A

NCOR1 PPP2R3A ARHGAP12 ZNF79 MSH3 ADCY9

2.96e-051976965843_UP
DrugBeta-sistosterol [83-46-5]; Down 200; 9.6uM; MCF7; HT_HG-U133A

NCOR1 MAP9 BMPR2 PPP2R3A ZNF79 PCM1

2.96e-051976967332_DN
DrugLY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A

PPP2R3A TTLL5 AKAP13 SPOCK2 QSER1 PCM1

2.96e-051976961641_UP
DrugOxantel pamoate [68813-55-8]; Down 200; 6.6uM; MCF7; HT_HG-U133A

MLH3 COCH AKAP13 ADCY9 PCM1 ZNF248

3.05e-051986965338_DN
DrugMeglumine [6284-40-8]; Down 200; 20.4uM; PC3; HT_HG-U133A

PPP2R3A TTLL5 AKAP13 QSER1 SOCS6 CDH7

3.05e-051986966685_DN
DrugKarakoline [39089-30-0]; Up 200; 10.6uM; PC3; HT_HG-U133A

MYO9B FCN1 TTLL5 PKP4 AFF1 TEX15

3.14e-051996964297_UP
DrugMidodrine hydrochloride [3092-17-9]; Up 200; 13.8uM; PC3; HT_HG-U133A

BMPR2 MLH3 MYO9B GLI2 TTLL5 ZNF79

3.22e-052006967156_UP
DiseaseEndometrial cancer

MLH3 MSH3

3.32e-054702cv:C0007103
DiseaseEndometrial carcinoma

MLH3 MSH3

3.32e-054702cv:C0476089
DiseaseENDOMETRIAL CANCER

MLH3 MSH3

3.32e-054702608089
Diseasefocal segmental glomerulosclerosis (implicated_via_orthology)

MYO9A TRPC6

1.16e-047702DOID:1312 (implicated_via_orthology)
Diseasered blood cell density measurement

MYO9A FMN1 PKP4 ZNF429 OTUD4 AFF1 AKAP13 LILRA5 VPS13B

2.29e-04880709EFO_0007978
Diseaseautism spectrum disorder (implicated_via_orthology)

TCF20 PKP4 CHD6 KDM5D

4.77e-04152704DOID:0060041 (implicated_via_orthology)
DiseaseHereditary Non-Polyposis Colon Cancer Type 2

MLH3 MSH3

9.24e-0419702C1333991
DiseaseColorectal cancer, hereditary nonpolyposis, type 1

MLH3 MSH3

9.24e-0419702C2936783
DiseaseHereditary Nonpolyposis Colorectal Neoplasms

MLH3 MSH3

1.74e-0326702C0009405
DiseaseHereditary non-polyposis colorectal cancer syndrome

MLH3 MSH3

1.87e-0327702C1112155
DiseaseHereditary Nonpolyposis Colorectal Cancer

MLH3 MSH3

2.16e-0329702C1333990
Diseaserisk-taking behaviour

SPATS2L TCF20 TRPC6 TNRC6A MSH3 CEP126 REV3L

2.21e-03764707EFO_0008579

Protein segments in the cluster

PeptideGeneStartEntry
GSFHNSQNVSKADNR

PKP4

161

Q99569
QLSTSFQNAGHSFKK

nan

46

Q0VG73
ETNSSHAQSQKGKSS

AKAP13

636

Q12802
NSVTENKTKNASHNG

C19orf18

196

Q8NEA5
NGLSQKSSHKAKDNF

ATAD2

761

Q6PL18
TKSANKSGSSFVHQA

RANBP2

1441

P49792
SSGSQSQKFSSEHKN

OTUD4

396

Q01804
TKGHFSETNQHDSKN

QSER1

811

Q2KHR3
GKVFNNSASQSSTHK

FMN1

501

Q68DA7
TAQEKNRFHKNSDSG

PUM3

16

Q15397
LSSKFQFSSNKEQNG

PDGFC

26

Q9NRA1
HNNTAFSTKDKDNDN

ANGPTL7

266

O43827
SQFGSSNTSHENLQK

MSH3

201

P20585
SQNKSDSGTASHLQD

LILRA5

246

A6NI73
KSHQGEKNASSSQAS

MAGEB2

86

O15479
NHNSLKSDENKENSF

MAP9

276

Q49MG5
GNQNSLQHKDSGSSA

KDM5D

1506

Q9BY66
AHQRQNSSNNFTKKN

FSIP2

366

Q5CZC0
SNSNNNASLHEVKAG

CCDC88A

1596

Q3V6T2
SNSVNHNSYNGKETK

PCM1

936

Q15154
KAAKLHFSQLGNSEN

LRRC36

141

Q1X8D7
ATQDNSFNKNSKTHS

MLH3

941

Q9UHC1
SFNKNSKTHSNSNTT

MLH3

946

Q9UHC1
NKAFSNASDRAKHQN

GLI2

541

P10070
LAKGKNSNFLNSHSQ

PPP2R3A

531

Q06190
DLTHNNGKFNNDSHS

ARHGAP12

151

Q8IWW6
NGKFNNDSHSPKVSS

ARHGAP12

156

Q8IWW6
NSLTGHNNNFFSTKD

FCN1

246

O00602
SHGNFSKQELKNLQS

CD1E

81

P15812
NSNQSFHSEGSLQKG

BCL7C

96

Q8WUZ0
SSKRSENINHNSAFK

C6

286

P13671
EKNFSFLTKGANQHN

CHD6

716

Q8TD26
NNAENSHSLKNKTGT

CEP126

641

Q9P2H0
KENQNHSYSLKSSAS

ITGAV

941

P06756
NNKTSFNSILNETAH

CCDC73

571

Q6ZRK6
QQNSSRHTKAGKTDA

CREBL2

101

O60519
NNNGSNRAVHSKSST

BMPR2

1001

Q13873
STDNNFHNDASTKKA

CCDC144B

416

Q3MJ40
QNGCQDEHKNSTKAS

ADCY9

651

O60503
TNNHNFSLKDNKDNT

CDH7

526

Q9ULB5
NSNTGKALKHTAQKF

COCH

241

O43405
HNSGNSQTKQKSTSF

MUCL3

211

Q3MIW9
DATHFSSNNSGTDKN

RP1

611

P56715
SKQNSDHSNGSFNLK

GTF2E2

51

P29084
QNNGNVAHFDSGSSK

TMC3

766

Q7Z5M5
SGKQSNFSRKSSTHN

SPATS2L

381

Q9NUQ6
DNNSGQSAIKHNVKS

NCOR1

1391

O75376
NEFHTANLSTKDNGN

SGO2

566

Q562F6
NHKKQSNGSQSRNCT

SPTLC3

16

Q9NUV7
NQKQYDTSSKTHSNS

AFF1

401

P51825
TSGNKHNNNGFQQKA

CKAP2L

401

Q8IYA6
KFSSQQAATKQSNAS

PSIP1

91

O75475
ANFTRSGNKLNHQKD

FYTTD1

171

Q96QD9
SFNFSDLNHSKNKVS

REV3L

706

O60673
QATDHQKNLGSSKDS

SPEM3

826

A0A1B0GUW6
QAGKTSQAHQSNSNA

SLCO4C1

346

Q6ZQN7
SQAHQSNSNADVKFG

SLCO4C1

351

Q6ZQN7
KFSSSNSQKIRHTGN

ZNF723

156

P0DPD5
GKSFSQSSNLTNHQR

ZNF256

581

Q9Y2P7
QKKHFDNRESQANSG

ZNF274

396

Q96GC6
SKSQASFNNKKSGDH

TCF20

936

Q9UGU0
NFQKTSEAQASAGHK

VPS13B

3776

Q7Z7G8
FGNAFNQSSALTNHK

ZNF429

206

Q86V71
KNGDSQHSASSANVF

TASOR2

1991

Q5VWN6
NDCNQKQKHDSFSHS

TRPC6

256

Q9Y210
GDKKQDSHTNENFSN

TEX15

501

Q9BXT5
GKAFNQSSSLSQHQR

ZNF79

451

Q15937
EQANSLKSSASHNGD

SOCS6

186

O14544
NSKNQSDINHSTSGS

TNRC6A

191

Q8NDV7
ENGSNFSKKSHLTQL

ZNF248

356

Q8NDW4
VFLGTHSKISKNNNN

TTLL5

816

Q6EMB2
HSKISKNNNNYSDSG

TTLL5

821

Q6EMB2
KNNNNYSDSGAKGDH

TTLL5

826

Q6EMB2
QLLHENSKQNGSASS

SPOCK2

216

Q92563
SGKFTSKSNSFNNHQ

ZNF776

241

Q68DI1
NSKLTHLNFSSNKLG

NLRP13

781

Q86W25
AFGNAKTAHNNNSSR

MYO9A

281

B2RTY4
AFGNAKTAHNNNSSR

MYO9B

281

Q13459